Sucampo Pharmaceuticals, Inc. SCMP
No live quote for SCMP yet.
SCMP revenue history
Revenue is income from the company’s ordinary business activities.
230,056,000 USD
FY 2016 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2016 | 2016-12-31 | 230,056,000 | 76,876,000 | 50.19% |
| FY 2015 | 2015-12-31 | 153,180,000 | 37,730,000 | 32.68% |
| FY 2014 | 2014-12-31 | 115,450,000 | 25,856,000 | 28.86% |
| FY 2013 | 2013-12-31 | 89,594,000 | 8,107,000 | 9.95% |
| FY 2012 | 2012-12-31 | 81,487,000 | 26,726,000 | 48.80% |
| FY 2011 | 2011-12-31 | 54,761,000 | -7,109,000 | -11.49% |
| FY 2010 | 2010-12-31 | 61,870,000 | -5,481,000 | -8.14% |
| FY 2009 | 2009-12-31 | 67,351,000 | -44,772,000 | -39.93% |
| FY 2008 | 2008-12-31 | 112,123,000 | 20,232,000 | 22.02% |
| FY 2007 | 2007-12-31 | 91,891,000 | 32,625,000 | 55.05% |
| FY 2006 | 2006-12-31 | 59,266,000 | 19,061,000 | 47.41% |
| FY 2005 | 2005-12-31 | 40,205,000 | 36,365,717 | 947.20% |
| FY 2004 | 2004-12-31 | 3,839,283 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:03.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
